Upload
Featured Recent Articles Topics Login Upload

Search Results for '2011-Cll'

2011-Cll published presentations and documents on DocSlides.

CLL Stromal cell protect
CLL Stromal cell protect
by tawny-fly
CLL Stromal cell protect Conventional therapies V...
Update on chronic lymphocytic leukemia (CLL) treatment
Update on chronic lymphocytic leukemia (CLL) treatment
by joy
Dr Mona Yuklea. Hematology Department, Meir Hospi...
Confirmation Hymns reproduced under licence CLL 27398 and Calamus 0269
Confirmation Hymns reproduced under licence CLL 27398 and Calamus 0269
by carny
Mallaig. Sprinkling Song . Spirit of God, come dw...
2022-2023 CLLS Continuing Libraries
2022-2023 CLLS Continuing Libraries
by hazel
Application Information Session. Thursday, April 7...
Hull CLLD Grants Community-Led Local Development
Hull CLLD Grants Community-Led Local Development
by celsa-spraggs
Session Agenda. Section 1 . – . CLLD Essentials...
Guidance on CLLD for local
Guidance on CLLD for local
by test
actors. Key messages . Paul Soto. Target:- . pote...
LEADER/CLLD
LEADER/CLLD
by mitsue-stanley
gahering. : Role of . bottom. -up . approach. . ...
Clonal Evolution in CLL:
Clonal Evolution in CLL:
by karlyn-bohler
Impact . on t. iming . of . therapy. Nicholas Chi...
Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma
Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma
by conchita-marotz
ASH Review 2012. Stephen Spurgeon (spurgeos@ohsu....
Case 2012-09
Case 2012-09
by tawny-fly
Diagnostic Slide Session. AANP - Annual Meeting. ...
Making Sense of Novel Prognostics: NOTCH1, SF3B1
Making Sense of Novel Prognostics: NOTCH1, SF3B1
by olivia-moreira
Jennifer R Brown, MD PhD. Director, CLL Center. D...
CLL: clinical cases Celso Arrais
CLL: clinical cases Celso Arrais
by genevieve
Conflict of Interests. I declare NO relevant confl...
Research To Practice ASH 2022 CLL Updates
Research To Practice ASH 2022 CLL Updates
by erica
John N. Allan. Associate Professor of Clinical Med...
Dr.V.Shanthi Associate Professor , Pathology
Dr.V.Shanthi Associate Professor , Pathology
by luna
Sri . Venkateswara. Institute of Medical Sciences...
Hima Darapu, MD Princeton Baptist Medical Center
Hima Darapu, MD Princeton Baptist Medical Center
by felicity
Baptist Health systems Alabama. Baseline Flow Cyto...
groupoflymphoidmalignancieswhichshareclinicalandprognosticfeaturesofin
groupoflymphoidmalignancieswhichshareclinicalandprognosticfeaturesofin
by erica
Table1ClinicalandimagingcharacteristicsofBcellindo...
uidelines
uidelines
by stella
Pan - London Haemato - O ncology Clinical G Lymph...
Reproducible diagnosis of
Reproducible diagnosis of
by davis
Title: Chronic Lymphocytic Leukemia by flow cyto...
Chronic Lymphocytic
Chronic Lymphocytic
by caitlin
A Guide for Being diagnosed with Chronic Lymphocy...
PATIENT EDUCATION
PATIENT EDUCATION
by brooke
Introduction Chronic lymphocytic leukemia (CLL) is...
Module 3: Chronic Lymphocytic Leukemia
Module 3: Chronic Lymphocytic Leukemia
by CottonTails
Josie . Montegaard. , MSN, AGPCNP-BC. Matthew S . ...
Presenter : CR 周益聖
Presenter : CR 周益聖
by CottonTails
Supervisor: VS . 曾主任. Cell 152, 714–726, F...
Comparison between Time-
Comparison between Time-
by LifeOfTheParty
Limited,Venetoclax. -Based and Continuous Bruton ....
Survival and Clinical Aspects for Patients with Chronic Lymphocytic Leukemia in Kermanshah, Iran
Survival and Clinical Aspects for Patients with Chronic Lymphocytic Leukemia in Kermanshah, Iran
by Tigerwoods
Mehrdad. . Payandeh. Department of Hematology and...
CHARACTERIZATION AND MANAGEMENT OF SYNCHRONOUS DUAL HEMATOLOGICAL MALIGNANCIES
CHARACTERIZATION AND MANAGEMENT OF SYNCHRONOUS DUAL HEMATOLOGICAL MALIGNANCIES
by susan
Rouslan Kotchetkov. ,. MD, PhD. 1. , Erin Ellison...
Using DNA copy number aberrations to
Using DNA copy number aberrations to
by pamela
identify candidate drivers of . carcinogenesis in ...
C hronic lymphocytic
C hronic lymphocytic
by della
leukemia. Magdalena Olszewska-Szopa. Definition. C...
www.society -for- hematopathology.org
www.society -for- hematopathology.org
by yvonne
SH2021-XX . Marrow involvement by clonally-related...
Curriculum Guide 2012 French I
Curriculum Guide 2012 French I
by audrey
Unit Objectives Approx 15 week per unit New Essent...
Cyngor Cymuned Basle Hefo Chrugion
Cyngor Cymuned Basle Hefo Chrugion
by cora
Page13Bausley with Criggion Community CouncilDraft...
A Phase 1 Study of the Selective Phosphatidylinositol 3-Kinase-Delta (PI3K
A Phase 1 Study of the Selective Phosphatidylinositol 3-Kinase-Delta (PI3K
by windbey
δ. ) Inhibitor, . Idelalisib. (GS-1101) in Combi...
STRETCH N GROW EVERY MONDAY!!!!
STRETCH N GROW EVERY MONDAY!!!!
by yoshiko-marsland
STRETCH N GROW EVERY MONDAY!!!! June 3-24 CAMP FI...
Pharmacist Focus on BTK Inhibitors Moderator Shilpa Paul, PharmD, BCOP
Pharmacist Focus on BTK Inhibitors Moderator Shilpa Paul, PharmD, BCOP
by ellena-manuel
Pharmacist Focus on BTK Inhibitors Moderator Shil...
Interesting case conference
Interesting case conference
by natalia-silvester
Mary-Margaret Allen, MD. February 24, 2015. 58 . ...
iOS and Location Services
iOS and Location Services
by lois-ondreau
CS4521. Core Location. Framework to determine ...
iOS and Location Services
iOS and Location Services
by alexa-scheidler
CS4521. Core Location. Framework to determine ...
Personalized Therapy in Relapsed or Refractory CLL
Personalized Therapy in Relapsed or Refractory CLL
by kittie-lecroy
IWCLL Criteria for Treating CLL. Other Considerat...
Integration of Novel Therapies in WM and CLL : When and How
Integration of Novel Therapies in WM and CLL : When and How
by giovanna-bartolotta
Neil E Kay, M.D.. October 2014. Mayo Team. Deb Bo...
A Collision of Crises:
A Collision of Crises:
by mitsue-stanley
The case for aligning future capital investment w...
ELARD CONFERENCE 2016
ELARD CONFERENCE 2016
by natalia-silvester
State of Play of LEADER/CLLD . in the EU. John Gr...